Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Sheela, A."'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Fiona Turkes, Clare Peckitt, S. Esteban Moreno, D. Kohoutova, Ian Chau, Ruwaida Begum, C. Saffery, Sheela Rao, Naureen Starling, David Cunningham, G. Smith, Charlotte Fribbens, David Watkins, Elizabeth C Smyth, A. Renn, A. Tran, Elizabeth Cartwright, S. Hatt, E. Johnston
Publikováno v:
Annals of Oncology. 32:S555-S556
Autor:
Matthew Frampton, Nicola Valeri, Naureen Starling, D. Gonzalez de Castro, Avni Patel, Brian A Walker, Lina Yuan, Angela Gillbanks, Chiara Baratelli, Sheela Rao, Marco Gerlinger, David Cunningham, Clare Peckitt, L S Teixeira Mendes, David Watkins, A C Wotherspoon, Ruwaida Begum, Thomas Jones, N. Fotiadis, Sing Yu Moorcraft, Zakaria Eltahir, S. Hulkki Wilson, Ian Chau, Chiara Braconi
Publikováno v:
Annals of Oncology. 29:230-236
Background Targeted capture sequencing can potentially facilitate precision medicine, but the feasibility of this approach in gastrointestinal (GI) malignancies is unknown. Patients and methods The FOrMAT (Feasibility of a Molecular Characterisation
Autor:
C. Fong, D.K.W. Lau, M.B. Razzaq, H. Katifi, F. Arouri, David Cunningham, Charlotte Fribbens, Ian Chau, Naureen Starling, Sheela Rao, A. Macklin-Doherty, L. Cortez, D. Watkins, Reyes Gonzalez-Exposito, S. Li
Publikováno v:
Annals of Oncology. 32:S559
Autor:
D. Watkins, Naureen Starling, Sheela Rao, David Cunningham, Charlotte Fribbens, Ian Chau, J. Mencel, H. Lamont
Publikováno v:
Annals of Oncology. 32:S557
Autor:
S.-B. Kim, Laetitia Dahan, Jaume Capdevila, Marwan Fakih, Lars Henrik Jensen, Chenwei Tian, K.-L.G. Spindler, Duncan C. Gilbert, Marianne Grønlie Guren, Sheela Rao, Dirk Arnold, T. Kayyal, J-P. Spano, A. Demols, Stefano Tamberi, M.J. Jones, M. Cornfeld, M. Catlett
Publikováno v:
Annals of Oncology. 31:S1170-S1171
Autor:
A. Pacis, R. Shaikh, Sheela Rao, David Watkins, Sing Yu Moorcraft, C. Saffery, Anne M. Bowcock, Thomas Jones, F. Lefebvre, Shelize Khakoo, Ian Chau, Mark Lathrop, A C Wotherspoon, Ruwaida Begum, Yasser Riazalhosseini, David Cunningham, M. Munter, Naureen Starling, Hima Anbunathan, Eleftheria Kalaitzaki
Publikováno v:
Annals of Oncology. 31:S134-S135
Autor:
C. Saffery, Naureen Starling, Sheela Rao, Eleftheria Kalaitzaki, Ian Chau, Mike Hubank, Elizabeth Cartwright, K. von Loga, Fiona Turkes, A C Wotherspoon, David Watkins, David Cunningham, R. Powell, K. De Paepe
Publikováno v:
Annals of Oncology. 30:v251-v252
Background Checkpoint inhibitors (CPIs) have transformed treatment of many malignancies. However, to date, response to checkpoint blockade in unselected gastrointestinal (GI) cancers has been disappointing. Tumours which display a non-T-cell inflamed
Autor:
Asif Chaudry, Louise J. Barber, Marco Gerlinger, Beatrice Griffiths, Sheela Rao, A C Wotherspoon, Eleftheria Kalaitzaki, Angela Gillbanks, David Cunningham, Martin Forster, David Watkins, Ian Chau, S. Davies, Ruwaida Begum, S. Mansukhani, Retchel Lazaro-Alcausi, Naureen Starling, K. von Loga, Michael Davidson, Daniel Morganstein
Publikováno v:
Annals of Oncology. 30:v254
Background ICONIC is a single arm phase 2 trial investigating the safety and efficacy of 4 cycles pre-operative and 4 cycles post-operative FLOT-A in resectable OGA. We report results from the safety run-in phase and early translational biomarker dat
Autor:
Naureen Starling, David Cunningham, Fiona Turkes, D. Watkins, Daniel Morganstein, K. De Paepe, Sheela Rao, K. von Loga, Ian Chau, R. Crux, Eleftheria Kalaitzaki, Annette Musallam, Avani Athauda, Angela Riddell, Ruwaida Begum, James Kinross, N. Fotiadis, Marco Gerlinger, Julian Teare, Julian Marchesi
Publikováno v:
Annals of Oncology. 30:v248
Background 95% of metastatic colorectal cancers (mCRCs) have normal mismatch repair proficient (pMMR) expression and a stable microsatellite phenotype (MSS). As a consequence, checkpoint inhibiting immunotherapy currently plays no role in these tumou